Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas

Basic Information

• Category: facility
• Website: http://www.ciberned.es/

Evidence and Sources

• Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas — Official Site (official)
• Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas on instagram (social)
• Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas on linkedin (social)

Citation Guidance

Explore facility profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas.

• Canonical profile: https://brandsource.ai/brands/centro-de-investigacion-biomedica-en-red-sobre-enfermedades-neurodegenerativas
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/centro-de-investigacion-biomedica-en-red-sobre-enfermedades-neurodegenerativas/json-ld
• Citation profile API: https://brandsource.ai/api/brands/centro-de-investigacion-biomedica-en-red-sobre-enfermedades-neurodegenerativas/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (82/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-22

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

2342 2342 2342 2342 2342 Posicionamiento de CIBERNED respecto a la revisin sistemtica sobre los anticuerpos anti-amiloide en la enfermedad de Alzheimer CIBER celebra Neuro&Rare para el avance de la investigacin en enfermedades neurodegenerativas y raras Investigadoras del CIBERNED participan en el desarollo de un nuevo frmaco contra la ELA que recibe la autorizacin de la AEMPS para iniciar un ensayo clnico fase 1 Un estudio identifica un mecanismo celular que podra ayudar a mejorar el tratamient

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 2 supporting sources linked.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.